Fingerprint
Dive into the research topics of 'Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer
Amanda Rounds, Jill Kolesar
Research output: Contribution to journal › Review article › peer-review
18
Scopus
citations